A trial looking at having imatinib with or without surgery for gastrointestinal stromal tumours (EORTC 62063)

Cancer type:

Sarcoma
Soft tissue sarcoma

Status:

Results

Phase:

Phase 3

This trial was looking at having surgery with imatinib for gastrointestinal stromal tumours. The trial was for gastrointestinal stromal tumours (GIST) that had spread locally or to the liver.

Doctors often treat GIST that has spread with imatinib, and it stops the cancer coming back for a while. Doctors are always looking for ways to increase the amount of time before the GIST starts to come back. They thought that having surgery, as well as imatinib may help. 

The aim of this trial was to see if adding surgery to imatinib could increase the amount of time before GIST started to come back.

Summary of results

This trial was never finished so there are no results available. The researchers were unable to recruit enough patients.

Recruitment start:

Recruitment end:

How to join a clinical trial

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Chief Investigator

Dr Michael Leahy

Supported by

European Organisation for Research and Treatment of Cancer (EORTC)
NIHR Clinical Research Network: Cancer

Questions about cancer? Contact our information nurses

Freephone 0808 800 4040

Last review date

CRUK internal database number:

Oracle 5589

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Cara took part in a clinical trial

A picture of Cara

"I am glad that taking part in a trial might help others on their own cancer journey.”

Last reviewed:

Rate this page:

No votes yet
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page